Access cutting-edge metastatic castration-resistant prostate cancer (mcrpc) treatment through this phase 1/2 clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Tampa location
Preparing your pre-screening questions…
Access metastatic castration-resistant prostate cancer (mcrpc) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related metastatic castration-resistant prostate cancer (mcrpc) treatment provided free
Check if you qualify for this metastatic castration-resistant prostate cancer (mcrpc) clinical trial in Tampa, FL
No-Cost Study Care
Local to Tampa
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is researching a new drug called REGN15505 when used alone or in combination with cemiplimab or in combination with REGN4336 in adult patients with mCRPC and ccRCC. The goal is to explore new ways to treat these cancers by helping immune cells target and destroy cancer cells. The study will evaluate the use of REGN15505 when administered alone, in combination with cemiplimab, or in combination with REGN4336 for: * Any side effects of study drugs * How well the study drugs work * How much REGN15505, cemiplimab, and REGN4336 are in the blood at different times * If the body makes antibodies to REGN15505 or REGN4336, which may mean the study drugs will not work as well as expected * What is the best dose of REGN15505 when administered alone and with cemiplimab and the best dose of REGN15505 and REGN4336 when used in combination
Sponsor: Regeneron Pharmaceuticals
Yes, this clinical trial (NCT07594106) has an active research site in Tampa, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for metastatic castration-resistant prostate cancer (mcrpc) treatment options in Tampa, FL, this clinical trial (NCT07594106) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tampa research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced metastatic castration-resistant prostate cancer (mcrpc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all metastatic castration-resistant prostate cancer (mcrpc) clinical trials near you to find additional studies recruiting in your area.
See all prostate cancer clinical trials recruiting in Tampa — not just this study.
Browse Prostate Cancer Trials in Tampa →